Company: APXIF
Filing Date: 2025-01-22
Form Type: F-4
Source: 0001213900-25-005463
Chunk: 50

Company: APx Acquisition Corp. I
Filing Date: 2025-01-22
Form: F-4
Chunk 50
---
 the Private Placement Warrants. On September8, 2023, APx issued an unsecured promissory note to the Sponsor, pursuant to which APx could borrow up to $500,000, related to the ongoing expenses reasonably related to the business of the Company and the consummation of the Business Combination (the “Working Capital Promissory Note”). On February9, 2024, APx issued an amended and restated promissory note (the “Amended and Restated Note”), amending and restating the Working Capital Promissory Note to increase the maximum principal amount from $500,000 to $2,000,000 and to provide that, in addition to funding working capital needs, amounts under the Amended and Restated Note may be used for the purposes of making one or more payments to Continental Stock Transfer & Trust Company, a New York limited liability trust company, as Extension Payments (as defined in the Company’s definitive proxy statement filed with the Securities and Exchange Commission on November29, 2023, as amended). As of December29, 2024, $1,731,460 has been drawn under the Amended and Restated Promissory Note. If APx does not complete an initial business combination, it is unlikely that Sponsor will recover funds drawn by APx under the Amended and Restated Note. Conversely, if the Business Combination closes, APx will repay the Working Capital Loans to the Sponsor; •on August17, 2023, Mr. Bransfield, as borrower, entered into a secured credit line loan agreement, with Bioceres Group PLC, an indirect shareholder of Parent, as the lender, and UG Holdings LLC, an affiliate of Mr. Bransfield, as the pledgor (such agreement as amended, the “Sponsor Loan Agreement”). Mr. Bransfield, as borrower, also entered into a pledge and security agreement, with Bioceres Group PLC, as the lender, and UG Holdings LLC, as the pledgor, pursuant to which, in order to secure his obligations under the Sponsor Loan Agreement, he pledged 100,000 ordinary shares of Moolec Science SA as security. The Sponsor Loan Agreement was amended on September6, 2023 to increase the credit line from $250,000 to $275,000; on October12, 2023 to increase the credit line to $400,000; on November9, 2023 to increase the credit line to $1,000,000;